Cardiac amyloidosis with the E526V mutation of the fibrinogen A α-chain

New England Journal of Medicine

Volumn 359, Issue 26, 2008, Pages 2847-2848

  Mourad, Georges ^a   Delabre, Jean Philippe ^a   Garrigue, Valérie ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ADULT; ALPHA CHAIN; CASE REPORT; DEFIBRILLATOR; DISEASE CLASSIFICATION; ECHOGRAPHY; GENE MUTATION; HEART AMYLOIDOSIS; HEART ARRHYTHMIA; HUMAN; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; PROTEINURIA;

EID: 58149100172     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0805012     Document Type: Letter

References (5)

1. Wood MJ, Picard MH. Utility of echocardiography in the evaluation of individuals with cardiomyopathy. Heart 2004;90:707-12.
2. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186-93.
3. Perugini E, Rapezzi C, Piva T, et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 2006;92:343-9.
4. Benson MD, Liepnieks J, Uemichi T, Wheeler G, Correa R. Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain. Nat Genet 1993;3:252-5.
5. Grateau G, Delpech M. Fibrinogen. In: Sipe JD, ed. Amyloid proteins: the beta sheet conformation and disease. Weinheim, Germany: Wiley-VCH, 2005:657-64.